Generation of C-reactive protein and complement components in atherosclerotic plaques

American Journal of Pathology

Volumn 158, Issue 3, 2001, Pages 1039-1051

  Yasojima, K ^a   Schwab, C ^a   McGeer, E G ^a   McGeer, P L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; MESSENGER RNA;

AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING;

EID: 0035099170     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64051-5     Document Type: Article

References (62)

1. Atherosclerosis: An inflammatory disease
2. The complement system in atherosclerosis
3. Processes in atherogenesis: Complement activation
4. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research
5. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
6. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis
7. Cytomegalovirus and atheroselerosis
8. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas
9. Immunohistochemical localization of C-reactive protein binding sites in human aortic lesions by a modified streptavidin-biotin-staining method
10. Interactions of C-reactive protein with the complement system
11. CRP-mediated activation of complement in vivo
12. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
13. C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
14. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes
15. Serum C-reactive protein and infarct size in myocardial infarct in patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy
16. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment
17. Acute-phase proteins and other systemic responses to inflammation
18. The chemistry, biology, and phylogeny of C3
19. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
20. Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer disease
21. Upregulated production and activation of the complement system in Alzheimer's disease brain
22. Complement gene expression by rabbit heart: Upregulation by ischemia and reperfusion
23. Human heart generates complement proteins that are upregulated and activated after myocardial infarction
24. Quantification of mRNA by nonradioactive RT-PCR and CCD imaging system
25. Neurofibrillary tangles of Guam Parkinson-dementia are associated with reactive microglia and complement proteins
26. A simple sequentially repetitive multiple test procedure
27. Purification of human C-reactive protein by barium sulfate and preparative agarose electrophoresis
28. Purification in large scale and characterization of the human leukocyte adhesion glycoprotein GP90 (CD18)
29. Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain
30. Acute-phase proteins and other systemic responses to inflammation
31. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
32. Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall
33. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis
34. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque
35. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion
36. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions
37. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction
38. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes
39. Extensive postmortem stability of RNA from rat and human brain
40. The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain
41. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis
42. Regulation of major histocompatibility gene expression in human vascular smooth muscle cells
43. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation
44. Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin
45. Modulation of human aorta smooth muscle cell phenotype: A study of muscle-specific variants of vinculin, caldesmon and actin expression
46. The myofibroblast: A quarter century after its discovery
47. Expression of C-reactive protein by alveolar macrophages
48. Human alveolar macrophages and monocytes generate the functional classical pathway of complement in vitro
49. Role of inflammation in the pathogenesis of unstable coronary artery diseases
50. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men
51. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
52. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
53. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
54. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly
55. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes
56. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
57. Production of C-reactive protein and risk of coronary events in stable and unstable angina
58. C-reactive protein as a marker for acute coronary syndromes
59. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
60. C-reactive protein and outcome after ischemic stroke
61. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women